New Cellular-Connected RPM Devices Deliver Actionable Health Insights to Improve Outcomes and Support Value-Based Care PHILADELPHIA, April 1, 2025 /PRNewswire/...
NEW YORK, April 1, 2025 /PRNewswire/ -- MedFluencers, the physician-founded agency renowned for expert management of compliant and impactful healthcare...
Industry leading set of technologies to drive scalability, flexibility, and efficiency in biologics production RADNOR, Pa., April 1, 2025 /PRNewswire/...
Demand for Capital Rx's financially aligned, innovative, and tech-driven approach to healthcare and pharmacy benefit administration continues to accelerate NEW...
Expanding Thoracic Portfolio WARSAW, Ind., and ZUG, Switzerland, April 1, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX:...
Nationwide, independent survey results reaffirm company's impact on improving communication, engagement, and operational efficiency CHARLOTTE, N.C., April 1, 2025 /PRNewswire/...
LAUSANNE, Switzerland, April 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer,...
Study Captures Drivers and Deterrents to Digital Health to Inform Biopharma Cx, Commercialization and Marketing Efforts SAN FRANCISCO, April 1,...
Collaboration integrates comprehensive payer policy intelligence with Access Realization™ solutions to overcome market access complexity for life sciences products MORRISVILLE,...
Publication of Independent Study Heightens Demand for UroShield ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company” or “NanoVibronix”), a medical...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical (Nasdaq: ADGM), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, is...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical (Nasdaq: ADGM), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, is...
Randomized trial at LSU Health Shreveport will evaluate Seraph 100 Blood Filter's effectiveness in treating sepsis caused by wound infections....
– FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD...
1 April 2025Announcement no. 8 Updated biographies for board candidates at the upcoming Annual General Meeting Copenhagen, Denmark, April 1,...
Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management ProceduresROSELAND, N.J., April 01, 2025 (GLOBE NEWSWIRE)...
SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its...
Stay on TASK Infographic Infographic describing the four steps to being able to get vaccinated with confidence described by TASK...
Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in Europe Operating loss decreased by...
SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural...